CINPHA Stock Chart & Stats
kr17.26
kr0.01(0.10%)
At close: 4:00 PM EST
kr17.26
kr0.01(0.10%)
Day’s Range― - ―
52-Week Rangekr10.48 - kr19.64
Previous CloseN/A
Volume34.96K
Average Volume (3M)77.41K
Market Cap
kr556.59M
Enterprise Valuekr150.31M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.91
Shares Outstanding46,537,790
10 Day Avg. Volume45,057
30 Day Avg. Volume77,407
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)-4.58
Revenue Forecast (FY)kr93.63M
Cinclus Pharma Holding AB News
CINPHA FAQ
What was Cinclus Pharma Holding AB’s price range in the past 12 months?
Cinclus Pharma Holding AB lowest stock price was kr10.48 and its highest was kr19.64 in the past 12 months.
What is Cinclus Pharma Holding AB’s market cap?
Cinclus Pharma Holding AB’s market cap is kr556.59M.
When is Cinclus Pharma Holding AB’s upcoming earnings report date?
Cinclus Pharma Holding AB’s upcoming earnings report date is Aug 19, 2026 which is in 28 days.
How were Cinclus Pharma Holding AB’s earnings last quarter?
Cinclus Pharma Holding AB released its earnings results on May 13, 2026. The company reported -kr1.907 earnings per share for the quarter, missing the consensus estimate of N/A by -kr1.907.
Is Cinclus Pharma Holding AB overvalued?
According to Wall Street analysts Cinclus Pharma Holding AB’s price is currently Overvalued.
Does Cinclus Pharma Holding AB pay dividends?
Cinclus Pharma Holding AB does not currently pay dividends.
What is Cinclus Pharma Holding AB’s EPS estimate?
Cinclus Pharma Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cinclus Pharma Holding AB have?
Cinclus Pharma Holding AB has 46,537,790 shares outstanding.
What happened to Cinclus Pharma Holding AB’s price movement after its last earnings report?
Cinclus Pharma Holding AB reported an EPS of -kr1.907 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.401%.
Which hedge fund is a major shareholder of Cinclus Pharma Holding AB?
Currently, no hedge funds are holding shares in SE:CINPHA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology